Back to Results

EFTA00686965.pdf

Source: DOJ_DS9  •  Size: 322.9 KB  •  OCR Confidence: 85.0%
PDF Source (No Download)

Extracted Text (OCR)

From: To: Subject: Re: Hi Jeffrey Date: Thu, 09 Feb 2012 13:40:33 +0000 see you then On Feb 9, 2012, at 8:10 AM, Jeffrey epstein wrote: 5? Sony for all the typos .Sent from my iPhone On Feb 9, 2012, at 8:31 AM, < can set set an approximate time? > wrote: Ted J. Kaptchuk Associate Professor of Medicine Harvard Medical School Director, Program in Placebo Studies & Therapeutic Encounter Beth Israel Deaconess Medical Center Boston, MA 02215 Phone: Email: Web: www.programinplacebostudies.org On Feb 7, 2012, at 2:27 PM, Jeffrey Epstein wrote: ped martin novak On Tue, Feb 7, 2012 at 3:25 PMr what time? any office # at ted Ted J. Kaptchuk wrote: EFTA00686965 Associate Professor of Medicine Harvard Medical School Director, Program in Placebo Studies & Therapeutic Encounter Beth Israel Deaconess Medical Center Boston, MA 02215 Phone: Email: Web: www.programinplacebostudies.org On Feb 7, 2012, at 2:22 PM, Jeffrey Epstein wrote: On Tue, Feb 7, 2012 at 3:12 PM, < > wrote: Jeffrey, I think it may be a good idea to set up a time to meet on April 12 in Cambridge. As a location, I can offer my home office near Harvard Sq, my office at the medical school, or any tea shop in the area. Or do you have another preference? Suggest a time as I'm flexible that day. ted Ted J. Kaptchuk Associate Professor of Medicine Harvard Medical School Director, Program in Placebo Studies & Therapeutic Encounter Beth Israel Deaconess Medical Center Boston, MA 02215 Phone Email: Web: www.programinplacebostudies.org On Feb 6, 2012, at 5:53 PM, Jeffrey Epstein wrote: cambridge april 12, but phone availble before On Mon, Feb 6, 2012 at 5:15 PM, < > wrote: EFTA00686966 Hi Jeffrey, When is a good time to talk about placebo? When are you next in Cambridge? ted Ted J. Kaptchuk Associate Professor of Medicine Harvard Medical School Director, Program in Placebo Studies & Therapeutic Encounter Beth Israel Deaconess Medical Center Boston MA 02215 Phone Email: Web: www.pngraminplacebostudies.org On Jan 13, 2012, at 3:15 PM, Jeffrey Epstein wrote: Im in africa until the 27th On Fri, Jan 13, 2012 at 9:05 PM, < Hi Jeff, wrote: I'm around Monday, Martin Luther King day until 3pm. Is that a good day for a phone conversation? Alternatively, as the phone hasn't been too successful, should we meet in person? When are you in Cambridge next? ted Ted J. Kaptchuk Associate Professor of Medicine Harvard Medical School Director, Program in Placebo Studies & Therapeutic Encounter Beth Israel Deaconess Medical Center Boston, Phone: Email: Web: www.programinplacebostudies.org EFTA00686967 On Dec 25, 2011, at 1:31 PM, Jeffrey Epstein wrote: lets alk on tues On Sun, Dec 25, 2011 at 2:04 PM, < wrote: Is there a good time to check-in with you to get your feedback on the budget we sent you two weeks ago and on what issues would interest you in developing a partnership with our efforts in placebo studies? We're trying to think bot scientifically and strategically. Our team has all the intellectual and infrastructure resources of Harvard University and any input would be appreciated. Best, ted Ted J. Kaptchuk Associate Professor of Medicine Harvard Medical School Director, Program in Placebo Studies & Therapeutic Encounter Beth Israel Deaconess Medical Center Boston, MA 02215 Phone Email: Web: www.programinplacebostudies.org On Dec 5, 2011, at 2:41 PM, Jeffrey Epstein wrote: now? On Mon, Dec 5, 2011 at 1:26 PM, G > wrote: I tried calling you on November 28. No answer. Our work is getting enormous media attention. (Attached is an article in this week's New Yorker. I wished it had focused more on our science and less on me. We expect coverage by "60 Minutes" in January.) This is a critical time to develop our scientific and institutional roots at Harvard. We're EFTA00686968 looking for partners to help move our research along. Would there be another time you could talk by telephone? Best ted Ted J. Kaptchuk Associate Professor of Medicine Harvard Medical School Director, Program in Placebo Studies & Therapeutic Encounter Beth Israel Deaconess Medical Center Boston, MA 02215 Phone: Email: Web: www.programinplacebostudies.org •*►rrrrrrrrrrrrrrrrrrrrrrrrr******************************* The information contained in this communication is confidential, may be attorney-client privileged, may constitute inside information, and is intended only for the use of the addressee. It is the property of Jeffrey Epstein Unauthorized use, disclosure or copying of this communication or any part thereof is strictly prohibited and may be unlawful. If you have received this communication in error, please notify us immediately by return e-mail or by e-mail to jeevacation@gmail.com, and destroy this communication and all copies thereof, including all attachments. copyright -all rights reserved *********************************************************** The information contained in this communication is confidential, may be attorney-client privileged, may constitute inside information, and is intended only for the use of the addressee. It is the property of Jeffrey Epstein EFTA00686969 Unauthorized use, disclosure or copying of this communication or any part thereof is strictly prohibited and may be unlawful. If you have received this communication in error, please notify us immediately by return e-mail or by e-mail to jeevacation@gmail.com, and destroy this communication and all copies thereof, including all attachments. copyright -all rights reserved ■********************************************************** The information contained in this communication is confidential, may be attorney-client privileged, may constitute inside information, and is intended only for the use of the addressee. It is the property of Jeffrey Epstein Unauthorized use, disclosure or copying of this communication or any part thereof is strictly prohibited and may be unlawful. If you have received this communication in error, please notify us immediately by return e-mail or by e-mail to jeevacation@gmail.com, and destroy this communication and all copies thereof, including all attachments. copyright -all rights reserved ******* **************************************************** The information contained in this communication is confidential, may be attorney-client privileged, may constitute inside information, and is intended only for the use of the addressee. It is the property of Jeffrey Epstein Unauthorized use, disclosure or copying of this communication or any part thereof is strictly prohibited and may be unlawful. If you have received this communication in error, please notify us immediately by return e-mail or by e-mail to jeevacation@gmail.com, and destroy this communication and all copies thereof, including all attachments. copyright -all rights reserved The information contained in this communication is confidential, may be attorney-client privileged, may EFTA00686970 constitute inside information, and is intended only for the use of the addressee. It is the property of Jeffrey Epstein Unauthorized use, disclosure or copying of this communication or any part thereof is strictly prohibited and may be unlawful. If you have received this communication in error, please notify us immediately by return e-mail or by e-mail to jeevacation@gmail.com, and destroy this communication and all copies thereof, including all attachments. copyright -all rights reserved The information contained in this communication is confidential, may be attorney-client privileged, may constitute inside information, and is intended only for the use of the addressee. It is the property of Jeffrey Epstein Unauthorized use, disclosure or copying of this communication or any part thereof is strictly prohibited and may be unlawful. If you have received this communication in error, please notify us immediately by return e-mail or by e-mail to jeevacation@gmail.com, and destroy this communication and all copies thereof, including all attachments. copyright -all rights reserved EFTA00686971

Document Preview

PDF source document
This document was extracted from a PDF. No image preview is available. The OCR text is shown on the left.

Document Details

Filename EFTA00686965.pdf
File Size 322.9 KB
OCR Confidence 85.0%
Has Readable Text Yes
Text Length 8,200 characters
Indexed 2026-02-12T13:42:08.821154
Ask the Files